Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2003
08/21/2003US20030158173 NK 1 antagonists
08/21/2003US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds
08/21/2003US20030158155 Mmp-12 inhibitors
08/21/2003US20030158092 For therapy of glycoprotein aberration disorders (e.g., cystic fibrosis), including gene therapy
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157204 A plant extracts as immunomodulator treating autoimmune disorders, antiallergens treating hypersensitivity reactions; used as pharmaceuticals, cosmetics or dietary supplements
08/21/2003US20030157203 Method for inhibiting pathogenesis associated with particle-inhalation
08/21/2003US20030157144 Desaturase genes and uses thereof
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157099 Human trk receptors and neurotrophic factor inhibitors
08/21/2003US20030157084 Methods for preparing purified prostaglandin E synthase
08/21/2003US20030157032 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant
08/21/2003CA2516331A1 Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
08/21/2003CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003CA2476239A1 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003CA2476162A1 Jnk inhibitor
08/21/2003CA2476113A1 Beta-sheet mimetics and composition and methods relating thereto
08/21/2003CA2475928A1 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003CA2475838A1 Cytotoxic t-cell epitopes from chlamydia
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475545A1 Use of anethole dithiolethione in lung cancer chemoprevention
08/21/2003CA2474885A1 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003CA2474626A1 Carboxylic acid compounds for use as surfactants
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2372785A1 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335923A2 Condensed pyridoindole derivatives
08/20/2003EP1335917A2 Condensed pyridoindole derivatives
08/20/2003EP1335916A1 Pyridyl-substituted triazoles as tgf inhibitors
08/20/2003EP1335740A1 Method and preparations having effect against allergic symptoms
08/20/2003EP1335729A2 Inhalative solution formulation containing a tiotropium salt
08/20/2003EP1335728A1 Novel medicament compositions based on tiotropium salts and on salmeterol salts
08/20/2003EP1335706A2 Microspheres of pancreatic enzymes with high stability
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1075489B1 Water-soluble prodrugs of 2,6-diisopropylphenol analogues
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0877609B1 Formulation for intranasal administration
08/20/2003EP0799040B1 Trisubstituted thioxanthines
08/20/2003CN1437605A Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437576A Substituted aminomethyl-phenyl-cyclohexane derivatives
08/20/2003CN1437575A Aminomethyl-phenyl-cyclohexanone derivatives
08/20/2003CN1437480A Compositions and methods for treatment of mucosal infections
08/20/2003CN1437472A Highly concentrated stable meloxicam solutions
08/20/2003CN1437471A Benzothiazole derivatives
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1436555A Medicine composition for treating acute pharyngitis and its prepn
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118296C Balsam pear lozenge and its producing method
08/20/2003CN1118287C Health-care medicine
08/20/2003CN1118277C Medical aerosol for treating diseases of respiratory system
08/20/2003CN1118250C Composition, cigarette and cigarette filtering tip
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608104 Gem substituted hydroxamic acids
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608087 Gyrase inhibitors and uses thereof
08/19/2003US6608084 Treatment of human or non-human animal patient suffering from, or subject to, condition which can be ameliorated by administration of inhibitor of alpha 4 beta 1 mediated cell adhesion
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608077 Il-8 receptor antagonists
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6607882 Regulation of endogenous gene expression in cells using zinc finger proteins
08/19/2003US6607741 Conjugates of sodium channel blockers and methods of using the same
08/19/2003US6607730 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/19/2003CA2099061C Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
08/19/2003CA2079376C (bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2079375C (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
08/19/2003CA2071674C Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme
08/19/2003CA2070254C Thrombin inhibitors
08/14/2003WO2003066881A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066671A1 Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
08/14/2003WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form
08/14/2003WO2003066636A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/14/2003WO2003066629A2 Heteroaryl compounds useful as inhibitors of gsk-3
08/14/2003WO2003066621A1 Piperidine derivatives and their use as antagonists of tachykinins
08/14/2003WO2003066620A1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
08/14/2003WO2003066618A1 Cytoprotective benzofuran derivatives
08/14/2003WO2003066598A1 Novel anhydrous amorphous forms of montelukast sodium salt
08/14/2003WO2003066594A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
08/14/2003WO2003066593A2 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
08/14/2003WO2003066591A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066590A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
08/14/2003WO2003066589A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
08/14/2003WO2003066577A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003WO2003066065A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066060A2 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
08/14/2003WO2003066050A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
1 ... 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 ... 878